Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot placebo-controlled trial

OBJECTIVE: Obsessive-compulsive disorder (OCD) affects approximately 2.5% of the population and is associated with significant morbidity. Many patients receive little benefit from the best available treatments, and even those who do respond often suffer from significant residual symptoms. Convergent...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Psychiatry
Asıl Yazarlar: Pittenger, Christopher, Bloch, Michael H., Wasylink, Suzanne, Billingslea, Eileen, Simpson, Ryan, Jakubovski, Ewgeni, Kelmendi, Ben, Sanacora, Gerard, Coric, Vladimir
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4560666/
https://ncbi.nlm.nih.gov/pubmed/26214725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.14m09123
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller